Drug Profile
Polymer-enhanced surfactant
Alternative Names: Inactivation-resistant surfactant; Surfactant - Karolinska Institute/UCSF/University of RochesterLatest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Surfactants
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Meconium aspiration syndrome; Neonatal respiratory distress syndrome
Most Recent Events
- 14 Jun 1999 Preclinical development for Meconium aspiration syndrome in USA (Intratracheal)
- 14 Jun 1999 Preclinical development for Neonatal respiratory distress syndrome in USA (Intratracheal)